Cargando…
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400417/ https://www.ncbi.nlm.nih.gov/pubmed/37355734 http://dx.doi.org/10.1038/s41375-023-01947-4 |
| _version_ | 1785084441146687488 |
|---|---|
| author | Diamond, Eli L. Francis, Jasmine H. Lacouture, Mario E. Rotemberg, Veronica Yabe, Mariko Petrova-Drus, Kseniya Ulaner, Gary A. Reddy, Ryan Abdel-Wahab, Omar Durham, Benjamin H. |
| author_facet | Diamond, Eli L. Francis, Jasmine H. Lacouture, Mario E. Rotemberg, Veronica Yabe, Mariko Petrova-Drus, Kseniya Ulaner, Gary A. Reddy, Ryan Abdel-Wahab, Omar Durham, Benjamin H. |
| author_sort | Diamond, Eli L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10400417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104004172023-08-05 CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition Diamond, Eli L. Francis, Jasmine H. Lacouture, Mario E. Rotemberg, Veronica Yabe, Mariko Petrova-Drus, Kseniya Ulaner, Gary A. Reddy, Ryan Abdel-Wahab, Omar Durham, Benjamin H. Leukemia Letter Nature Publishing Group UK 2023-06-24 2023 /pmc/articles/PMC10400417/ /pubmed/37355734 http://dx.doi.org/10.1038/s41375-023-01947-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Diamond, Eli L. Francis, Jasmine H. Lacouture, Mario E. Rotemberg, Veronica Yabe, Mariko Petrova-Drus, Kseniya Ulaner, Gary A. Reddy, Ryan Abdel-Wahab, Omar Durham, Benjamin H. CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title | CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title_full | CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title_fullStr | CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title_full_unstemmed | CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title_short | CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition |
| title_sort | csf1r inhibition for histiocytic neoplasm with cbl mutations refractory to mek1/2 inhibition |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400417/ https://www.ncbi.nlm.nih.gov/pubmed/37355734 http://dx.doi.org/10.1038/s41375-023-01947-4 |
| work_keys_str_mv | AT diamondelil csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT francisjasmineh csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT lacouturemarioe csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT rotembergveronica csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT yabemariko csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT petrovadruskseniya csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT ulanergarya csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT reddyryan csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT abdelwahabomar csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition AT durhambenjaminh csf1rinhibitionforhistiocyticneoplasmwithcblmutationsrefractorytomek12inhibition |